NASDAQ: JYNTJoint Corp Stock
$11.02+0.00 (+0%)
Updated Jun 18, 2025
JYNT Price
$11.02
Fair Value Price
$5.88
Market Cap
$168.64M
52 Week Low
$9.58
52 Week High
$15.32
P/E
-19x
P/B
8.47x
P/S
2.16x
PEG
N/A
Dividend Yield
N/A
Revenue
$87.98M
Earnings
-$8.68M
Gross Margin
86.6%
Operating Margin
-9.53%
Profit Margin
-9.9%
Debt to Equity
2.88
Operating Cash Flow
$3M
Beta
1.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
JYNT Overview
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine JYNT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
JYNT
Ranked#33 of 42
Ranked#33 of 42
Be the first to know about important JYNT news, forecast changes, insider trades & much more!
JYNT News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how JYNT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
JYNT ($11.02) is overvalued by 87.53% relative to our estimate of its Fair Value price of $5.88 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
JYNT ($11.02) is not significantly undervalued (87.53%) relative to our estimate of its Fair Value price of $5.88 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
JYNT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more JYNT due diligence checks available for Premium users.
Valuation
JYNT fair value
Fair Value of JYNT stock based on Discounted Cash Flow (DCF)
Price
$11.02
Fair Value
$5.88
Overvalued by
87.53%
JYNT ($11.02) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
JYNT ($11.02) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
JYNT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
JYNT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-19x
Industry
16.49x
Market
28.67x
JYNT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
8.47x
Industry
4.56x
JYNT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
JYNT's financial health
Profit margin
Revenue
$13.1M
Net Income
$801.4k
Profit Margin
6.1%
JYNT's Earnings (EBIT) of -$8.38M... subscribe to Premium to read more.
Interest Coverage Financials
JYNT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$77.2M
Liabilities
$57.3M
Debt to equity
2.88
JYNT's short-term assets ($67.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
JYNT's short-term assets ($67.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
JYNT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
JYNT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.7M
Investing
-$291.4k
Financing
$893.2k
JYNT's operating cash flow ($2.90M)... subscribe to Premium to read more.
Debt Coverage Financials
JYNT vs Medical Care Facility Stocks
Joint Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.